[Thrombocardiology].
作者信息
Møller Mogens, Mickley Hans
出版信息
Ugeskr Laeger. 2002 Sep 2;164(36):4157.
PMID:12362824
Abstract
摘要
相似文献
1
[Thrombocardiology].
Ugeskr Laeger. 2002 Sep 2;164(36):4157.
2
[Clinical pharmacology of drugs used in thromboembolism].
Pol Tyg Lek. 1983;38(51-52):1663-7.
3
[Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
MMW Fortschr Med. 2006 Apr 13;148(15):31.
4
Antithrombotic treatment in atrial fibrillation.
Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944.
5
Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
Pharmacoepidemiol Drug Saf. 2007 Jan;16(1):32-8. doi: 10.1002/pds.1329.
6
Bleeding while starting anticoagulation for thromboembolism prophylaxis in elderly patients with atrial fibrillation: from bad to worse.
Circulation. 2007 May 29;115(21):2684-6. doi: 10.1161/CIRCULATIONAHA.107.704122.
7
[Summary of symposium on prevention of thrombotic risk in elderly].
Rev Med Interne. 2004 Sep;25 Suppl 3:S318-24.
8
[Value of full heparinization in venoatrial acute thromboembolic insult].
Dtsch Med Wochenschr. 2003 Mar 14;128(11):569-70. doi: 10.1055/s-2003-37848.
9
Antithrombotic therapy for stroke prevention in atrial fibrillation.
Prog Cardiovasc Dis. 2005 Sep-Oct;48(2):108-24. doi: 10.1016/j.pcad.2005.06.007.
10
New anticoagulants for atrial fibrillation.
J Cardiovasc Med (Hagerstown). 2009 Jun;10(6):446-53. doi: 10.2459/JCM.0b013e3283249aee.
Zotero 插件